TABLE 2.
n | Genotype |
Additive model |
|||||
---|---|---|---|---|---|---|---|
AA | AC | CC | β | SE | P | ||
MPP | |||||||
Baseline | |||||||
BMI (kg/m2) | 12,326 | 24.0 ± 3.1 | 24.0 ± 3.1 | 24.0 ± 3.0 | −0.035 | 0.040 | 0.37 |
Fasting plasma glucose (mmol/l) | 12,328 | 5.41 ± 0.55 | 5.42 ± 0.54 | 5.42 ± 0.55 | 0.015 | 0.007 | 0.033 |
2-h plasma glucose (mmol/l) | 6,718 | 6.28 ± 1.58 | 6.36 ± 1.65 | 6.36 ± 1.67 | 0.050 | 0.026 | 0.052 |
Follow-up | |||||||
BMI (kg/m2) | 12,271 | 26.9 ± 3.9 | 26.8 ± 3.9 | 26.8 ± 3.9 | 0.023 | 0.051 | 0.65 |
Fasting plasma glucose (mmol/l) | 12,327 | 5.44 ± 0.54 | 5.46 ± 0.55 | 5.50 ± 0.55 | 0.033 | 0.007 | 1.2 × 10−6 |
PPP-Botnia Study | |||||||
BMI (kg/m2) | 2,991 | 26.1 ± 4.0 | 26.2 ± 4.2 | 26.1 ± 4.3 | 0.033 | 0.102 | 0.75 |
Fasting plasma glucose (mmol/l) | 2,994 | 5.13 ± 0.53 | 5.17 ± 0.56 | 5.20 ± 0.56 | 0.038 | 0.014 | 0.0067 |
2-h plasma glucose (mmol/l) | 2,976 | 5.08 ± 1.53 | 5.17 ± 1.56 | 5.23 ± 1.65 | 0.074 | 0.038 | 0.053 |
ISI | 2,838 | 145 (109) | 144 (111) | 144 (112) | 0.001 | 0.013 | 0.95 |
HOMA-IR | 2,939 | 0.60 (0.50) | 0.60 (0.50) | 0.60 (0.50) | 0.001 | 0.014 | 0.93 |
CIR | 2,849 | 166 (180) | 155 (158) | 157 (161) | −0.048 | 0.019 | 0.013 |
CIR adjusted for ISI | −0.051 | 0.019 | 0.0073 | ||||
DI | 2,814 | 23,464 (27,419) | 22,366 (25,013) | 21,866 (24,716) | −0.052 | 0.021 | 0.013 |
BPS | |||||||
Baseline | |||||||
BMI (kg/m2) | 2,123 | 25.8 ± 3.9 | 25.4 ± 3.9 | 25.7 ± 3.9 | −0.065 | 0.119 | 0.59 |
Fasting plasma glucose (mmol/l) | 2,128 | 5.59 ± 0.58 | 5.49 ± 0.56 | 5.53 ± 0.58 | −0.029 | 0.022 | 0.19 |
2-h plasma glucose (mmol/l) | 2,128 | 6.10 ± 1.45 | 6.08 ± 1.45 | 6.27 ± 1.50 | 0.072 | 0.048 | 0.13 |
ISI | 2,128 | 144 (106) | 154 (114) | 146 (109) | 0.014 | 0.018 | 0.42 |
HOMA-IR | 2,128 | 0.61 (0.42) | 0.57 (0.37) | 0.58 (0.43) | −0.015 | 0.016 | 0.34 |
CIR | 2,128 | 118 (131) | 115 (126) | 96 (117) | −0.089 | 0.025 | 3.6 × 10−4 |
CIR adjusted for ISI | −0.083 | 0.024 | 7.2 × 10−4 | ||||
DI | 2,128 | 15,934 (19,260) | 16,663 (19,049) | 14,102 (16,413) | −0.075 | 0.027 | 0.0058 |
Follow-up | |||||||
BMI (kg/m2) | 2,068 | 26.8 ± 4.2 | 26.4 ± 4.0 | 26.8 ± 4.3 | −0.051 | 0.136 | 0.71 |
Fasting plasma glucose (mmol/l) | 2,128 | 5.29 ± 0.57 | 5.30 ± 0.55 | 5.33 ± 0.60 | 0.032 | 0.018 | 0.077 |
2-h plasma glucose (mmol/l) | 2,128 | 5.77 ± 1.76 | 5.85 ± 1.67 | 6.00 ± 1.77 | 0.127 | 0.050 | 0.011 |
ISI | 2,127 | 101 (94) | 102 (85) | 96 (93) | −0.003 | 0.019 | 0.89 |
HOMA-IR | 2,125 | 0.97 (0.87) | 0.93 (0.76) | 0.96 (0.90) | −0.010 | 0.018 | 0.58 |
CIR | 2,128 | 160 (184) | 142 (160) | 130 (140) | −0.086 | 0.027 | 0.0018 |
CIR adjusted for ISI | −0.087 | 0.027 | 0.0013 | ||||
DI | 2,127 | 15,563 (21,424) | 14,322 (18,304) | 13,299 (17,404) | −0.089 | 0.030 | 0.0030 |
Meta analysis | |||||||
BMI (kg/m2) | 0.41 | ||||||
Fasting plasma glucose (mmol/l) | 0.0078 | ||||||
2-h plasma glucose (mmol/l) | 0.0021 | ||||||
ISI | 0.58 | ||||||
HOMA-IR | 0.57 | ||||||
CIR | 3.0 × 10−5 | ||||||
CIR adjusted for ISI | 2.7 × 10−5 | ||||||
DI | 2.5 × 10−4 |
Data are means ± SD or median (interquartile range) unless otherwise indicated. β and SE from linear regression analysis adjusted for age, sex, BMI, and within-pedigree dependence (BPS) denote the effect size by each C-allele (additive model) on phenotype. Meta-analysis includes the PPP-Botnia Study and the BPS at baseline. P values < 0.05 are in boldface.